Cargando…

The dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis

Light at night (LAN) is a ubiquitous environmental issue resulting from exposure to artificial light during the night-time hours. The adverse effects of LAN include circadian disruption, melatonin suppression and altered clock gene expression. Very recent evidence suggests that LAN may increase risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbano, T, Vinceti, M, Wise, L A, Filippini, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595687/
http://dx.doi.org/10.1093/eurpub/ckad160.572
_version_ 1785124927432556544
author Urbano, T
Vinceti, M
Wise, L A
Filippini, T
author_facet Urbano, T
Vinceti, M
Wise, L A
Filippini, T
author_sort Urbano, T
collection PubMed
description Light at night (LAN) is a ubiquitous environmental issue resulting from exposure to artificial light during the night-time hours. The adverse effects of LAN include circadian disruption, melatonin suppression and altered clock gene expression. Very recent evidence suggests that LAN may increase risk of several diseases, including cancer. Breast cancer is the most common diagnosed cancer globally and the second leading cause of cancer-related mortality. Several environmental and life-style related risk factors have been linked to breast cancer onset. In this updated meta-analysis, we investigated how exposure to LAN may affect breast cancer risk. Using systematic online database searches (PubMed, Scopus, and Web of Science), we included 19 eligible studies (10 cohort and 9 case-control) investigating the association between LAN, either outdoor or indoor, and breast cancer risk. We first performed a meta-analysis comparing the highest versus lowest levels of exposure. Then, we performed a dose-response meta-analysis to investigate the shape of such relation. Overall, we found a positive association between LAN and breast cancer (risk ratio [RR] 1.08, 95% confidence interval-CI 1.03-1.13). In stratified analyses, the risk was more pronounced in premenopausal (RR 1.15, 95% CI 1.05-1.26) and normal-weighted (RR 1.17, 95% CI 1.00-1.36) women, while stratifying for outdoor/indoor exposure and for estrogen receptor status did not gave substantial differences in the risk estimates. The dose-response relation showed a linear risk increase up to 60 nW/cm(2)/sr after which the curve reached a plateau, especially among premenopausal women. These results strengthen the hypothesis that LAN is associated with breast cancer risk. Public health measures are warranted to minimize LAN exposure and reduce its related adverse effects on human health. KEY MESSAGES: • Light at night is positively associated with breast cancer risk. • The dose–response relation between light at night and breast cancer supports a positive association particularly in premenopausal women.
format Online
Article
Text
id pubmed-10595687
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105956872023-10-25 The dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis Urbano, T Vinceti, M Wise, L A Filippini, T Eur J Public Health Parallel Programme Light at night (LAN) is a ubiquitous environmental issue resulting from exposure to artificial light during the night-time hours. The adverse effects of LAN include circadian disruption, melatonin suppression and altered clock gene expression. Very recent evidence suggests that LAN may increase risk of several diseases, including cancer. Breast cancer is the most common diagnosed cancer globally and the second leading cause of cancer-related mortality. Several environmental and life-style related risk factors have been linked to breast cancer onset. In this updated meta-analysis, we investigated how exposure to LAN may affect breast cancer risk. Using systematic online database searches (PubMed, Scopus, and Web of Science), we included 19 eligible studies (10 cohort and 9 case-control) investigating the association between LAN, either outdoor or indoor, and breast cancer risk. We first performed a meta-analysis comparing the highest versus lowest levels of exposure. Then, we performed a dose-response meta-analysis to investigate the shape of such relation. Overall, we found a positive association between LAN and breast cancer (risk ratio [RR] 1.08, 95% confidence interval-CI 1.03-1.13). In stratified analyses, the risk was more pronounced in premenopausal (RR 1.15, 95% CI 1.05-1.26) and normal-weighted (RR 1.17, 95% CI 1.00-1.36) women, while stratifying for outdoor/indoor exposure and for estrogen receptor status did not gave substantial differences in the risk estimates. The dose-response relation showed a linear risk increase up to 60 nW/cm(2)/sr after which the curve reached a plateau, especially among premenopausal women. These results strengthen the hypothesis that LAN is associated with breast cancer risk. Public health measures are warranted to minimize LAN exposure and reduce its related adverse effects on human health. KEY MESSAGES: • Light at night is positively associated with breast cancer risk. • The dose–response relation between light at night and breast cancer supports a positive association particularly in premenopausal women. Oxford University Press 2023-10-24 /pmc/articles/PMC10595687/ http://dx.doi.org/10.1093/eurpub/ckad160.572 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Parallel Programme
Urbano, T
Vinceti, M
Wise, L A
Filippini, T
The dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis
title The dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis
title_full The dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis
title_fullStr The dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis
title_full_unstemmed The dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis
title_short The dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis
title_sort dark side of light at night: assessing breast cancer risk with a dose-response meta-analysis
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595687/
http://dx.doi.org/10.1093/eurpub/ckad160.572
work_keys_str_mv AT urbanot thedarksideoflightatnightassessingbreastcancerriskwithadoseresponsemetaanalysis
AT vincetim thedarksideoflightatnightassessingbreastcancerriskwithadoseresponsemetaanalysis
AT wisela thedarksideoflightatnightassessingbreastcancerriskwithadoseresponsemetaanalysis
AT filippinit thedarksideoflightatnightassessingbreastcancerriskwithadoseresponsemetaanalysis
AT urbanot darksideoflightatnightassessingbreastcancerriskwithadoseresponsemetaanalysis
AT vincetim darksideoflightatnightassessingbreastcancerriskwithadoseresponsemetaanalysis
AT wisela darksideoflightatnightassessingbreastcancerriskwithadoseresponsemetaanalysis
AT filippinit darksideoflightatnightassessingbreastcancerriskwithadoseresponsemetaanalysis